Novocure (NVCR) | Stock Overview & Key Data

Novocure Ltd. | Small-cap | Healthcare

$17.91

2.02%

| Novocure Stock Comparison:

Novocure vs Abbott Laboratories Novocure vs Boston Scientific Novocure vs UFP Technologies Novocure vs Alphatec Holdings Novocure vs Enovis Novocure vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Novocure Performance Comparison

Loading chart data...

Novocure

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $17.20 High: $18.02

on June 17, 2025

52 Week Range

Low: $14.17 High: $34.13

on October 8, 2024

on December 18, 2024

All-Time High: $232.76 on June 21, 2021

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $2.0B

EPS i -1.51

P/E Ratio (TTM) i -11.25

Forward P/E i -11.70

P/B Ratio i 5.40

PEG Ratio i -11.70

Div. Yield i 0.00%

ROE i -45.52%

Beta i 0.746

Debt to Equity i 192.49

Financial Highlights

Profitability

Gross Margin i 75.15%

Operating Margin i -24.43%

Profit Margin i -26.41%

Returns and Earnings

Return on Assets (TTM) i -8.64%

Return on Equity (TTM) i -45.52%

EBITDA i $-153.5M

Net Income (TTM) i $-164.2M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Novocure NVCR	1.96B Small-cap	5.98%	0.11%	-8.58%	-43.59%	-40.28%	-17.76%	-69.74%	-72.31%
Abbott Laboratories ABT	235.96B Mega-cap	0.46%	-0.59%	4.99%	18.99%	18.13%	30.81%	32.27%	49.56%
Boston Scientific BSX	147.56B Large-cap	1.45%	-4.29%	2.62%	12.19%	13.55%	29.94%	176.98%	172.59%
UFP Technologies UFPT	1.80B Small-cap	-0.28%	-6.23%	9.82%	-3.83%	-3.53%	-7.45%	218.35%	430.63%
Alphatec Holdings ATEC	1.62B Small-cap	-7.55%	-14.97%	13.03%	16.37%	21.63%	3.75%	69.37%	114.76%
Enovis ENOV	1.82B Small-cap	-1.95%	-10.57%	-17.71%	-29.57%	-27.20%	-28.86%	-43.52%	-32.90%

Ownership & Short Interest

Insider Ownership i 9.87%

Institutional Ownership i 87.41%

Shares Short i 5M

Short Ratio i 4.99

Short % of Shares Outstanding i 6.59%

Average 10-Day Volume i 2M

Average 90-Day Volume i 1M

Novocure Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Novocure would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is NVCR's 52-week high and low?

In the last 52 weeks, Novocure reached a high of $34.13 (on December 18, 2024) and a low of $14.17 (on October 8, 2024).

What is the market cap and P/E ratio for NVCR?

Curious about Novocure's size and valuation? Its market capitalization stands at 1.96B. When it comes to valuation, the P/E ratio (trailing twelve months) is -11.25, and the forward P/E (looking ahead) is -11.70.

Does NVCR pay dividends? If so, what's the yield?

As for dividends, Novocure isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Novocure's main competitors or similar companies to consider before investing?

When looking at Novocure, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Abbott Laboratories ABT	235.96B	Healthcare	Medical Devices	30.81%	32.27%
Boston Scientific BSX	147.56B	Healthcare	Medical Devices	29.94%	176.98%
UFP Technologies UFPT	1.80B	Healthcare	Medical Devices	-7.45%	218.35%
Alphatec Holdings ATEC	1.62B	Healthcare	Medical Devices	3.75%	69.37%
Enovis ENOV	1.82B	Healthcare	Medical Devices	-28.86%	-43.52%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Novocure Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Novocure's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -45.52%, the Debt to Equity ratio from the most recent quarter is 192.49, and its Gross Profit Margin stands at 75.15%.

What is the recent revenue and earnings growth for NVCR?

Looking at Novocure's growth, its revenue over the trailing twelve months (TTM) was $622M. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.90%, and quarterly earnings saw a YoY growth of 11.91%.

How much of NVCR stock is held by insiders and institutions?

Wondering who owns Novocure stock? Company insiders (like executives and directors) hold about 9.87% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 87.41%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.